These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2098914)

  • 21. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC; Wassom DL
    J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Scanning electron microscopic observations of ookinete formation of Plasmodium yoelii yoelii in vitro].
    Gao XZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1989; 7(1):53-5. PubMed ID: 2766499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimalaric effect of an alcoholic extract of Artemisia ludoviciana mexicana in a rodent malaria model.
    Malagón F; Vázquez J; Delgado G; Ruiz A
    Parassitologia; 1997 Mar; 39(1):3-7. PubMed ID: 9419840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Morphological characteristics of Plasmodium yoelii schizonts in ghost erythrocytes].
    Mao YH; Xu B; Liu BF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):263-7. PubMed ID: 15266827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the exoerythrocytic forms of Plasmodium yoelii yoelii in rats and mice].
    Zhang JX; Lin BY; Pan YR
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1990; 8(4):288-90. PubMed ID: 2099260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
    Shukla B; Dutta GP
    J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
    [No Abstract]   [Full Text] [Related]  

  • 30. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
    Singh C; Malik H; Puri SK
    J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
    Solomon VR; Puri SK; Srivastava K; Katti SB
    Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
    Neerja J; Puri SK
    Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chemotherapy of rodent malaria. XLIV. Studies on the mode of action of CM 6606, an indolo (3,2-c) quinoline N-oxide.
    Peters W; Robinson BL; Mutambu SL; Warhurst DC; Ellis DS; Tovey DG
    Ann Trop Med Parasitol; 1989 Feb; 83(1):1-10. PubMed ID: 2688575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice.
    Ramos-Avila A; Ventura-Gallegos JL; Zentella-Dehesa A; Machuca-Rodríguez C; Moreno-Altamirano MM; Narváez V; Legorreta-Herrera M
    Scand J Immunol; 2007 Jan; 65(1):54-62. PubMed ID: 17212767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimalarial activity of tulathromycin in a murine model of malaria.
    Villarino N; Denny JE; Schmidt NW
    Antimicrob Agents Chemother; 2015; 59(6):3672-4. PubMed ID: 25870067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii.
    Rivera N; Ponce YM; Arán VJ; Martínez C; Malagón F
    Parasitol Res; 2013 Apr; 112(4):1523-7. PubMed ID: 23338979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of antimalarial activity of the alkaloidal fraction of Hydrangea macrophylla var. Otaksa leaves with the hot-water extract in ICR mice infected with Plasmodium yoelii 17 XL.
    Ishih A; Miyase T; Terada M
    Phytother Res; 2003 Jun; 17(6):633-9. PubMed ID: 12820231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of four drugs on intraerythrocytic Plasmodium yoelii of early and late stages].
    Chen XH; Hu YM
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S37-40. PubMed ID: 8010072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ultrastructural study on effect of primaquine on sporogonic stage of Plasmodium yoelii nigeriensis].
    Shi YL; Yang JD; Chen PH
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):282-4. PubMed ID: 2610001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.